Citations

Showing 10 of 108119 citations.

Abstract 238: Biological Role and Therapeutic Potential of Nitric Oxide Signaling in Aortic Valve Stenosis: Insights From Genetic Modulation of DDAH1
Roos, Carolyn M, Oehler, Elise A., Verzosa, Grace, Hagler, Michael A , Zhang, Bin , Arghami, Arman , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 12, 2019 | Volume: 38 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.38.suppl_1.238 Get It

The balance between local asymmetric dimethylarginine (ADMA) levels and dimethylarginine dimethylaminohydrolase 1 (DDAH1) activity is a major determinant of local nitric oxide synthase activity. Previous studies suggested that increased plasma ADMA levels are strongly associated with the aortic valve stenosis, causal or mechanistic links have yet to be elucidated. Thus, the aim of this study was to investigate whether reduction or overexpression of DDAH1 protects aortic valve dysfunction in mice. To experimentally alter DDAH1 levels, we used low density lipoprotein receptor deficient, apolipoprotein B100-only (LA) mice that were either DDAH1 wild-type (D +/+ or D 0/0 ), heterozygous (D +/- ), or transgenic/overexpressing (D Tg/0 ) littermates. All mice were fed a western diet for 6 months. Reducing DDAH1 increased plasma ADMA levels (LA-D +/+ =0.89 ± 0.02 μmol/L, LA-D +/- =1.1 ± 0.02 μmol/L, p< 0.05) and blood pressure (LA-D +/+ = 125 ± 4 mmHg, LA-D +/- = 141 ± 3 mmHg, p< 0.05) following 6 months of western diet feeding. Critically, aortic valve function was significantly worse in DDAH1-deficient mice (LA-D +/+ 2.20±0.09 m/sec versus LA-D +/- =2.41±0.11 m/sec, p< 0.05) and was associated with higher levels of valve cusp calcification (Alizarin Red, LA-D +/+ = 10 ± 3% versus LA-D +/- = 20 ± 4%). Reciprocally, overexpression of DDAH1 in hypercholesterolemic littermates reduced ADMA levels (LA-D 0/0 = 1.4 ± 0.2 μmol/L, LA-D Tg/0 = 0.7 ± 0.1μmol/L, p< 0.05) and systolic blood pressure (LA-D 0/0 = 136 ± 6 mmHg, LA-D Tg/0 = 124 ± 4 mmHg, p< 0.05). Interestingly, aortic valve function was not improved by overexpression of DDAH1 (LA-D 0/0 = 2.36 ± 0.06 m/sec versus LA-D Tg/0 mice (2.43 ± 0.21 m/sec), nor was valvular calcification. These results suggest that while endogenous levels of DDAH1 expression protect against increases in circulating ADMA, blood pressure, valvular calcification, and valvular dysfunction. Interestingly, overexpression of DDAH1 does not appear to confer additional protection against progression of valvular stenosis. Collectively, our data suggest effective therapeutic harnessing of the DDAH1/ADMA/NOS axis will require targeting of downstream effector molecules—such as oxidation state of soluble guanylate cyclase—known to be pathologically altered and rate limiting in a variety of cardiovascular diseases.
Abstract 156: Uric acid is an Independent Predictor of Plaque Stability and Future Cerebrovascular Events in Patients Undergoing Carotid Endarterectomy
Prasad, Megha , Nardi, Valentina , Lerman, Lilach O. , Lerman, Amir , Nardi, Valentina

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 12, 2019 | Volume: 38 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.38.suppl_1.156 Get It

Background: Uric acid is a known risk factor for atherosclerosis. We aimed to determine whether baseline uric acid levels predict plaque stability on presentation and future cerebrovascular events (CVA) in patients undergoing carotid endarterectomy (CEA). Methods: We analyzed 317 patients who underwent CEA between 2/2002 and 6/2017. Patients were stratified according to plaque stability as unstable or stable --those who presented with a history of > 1 neurologic event were “unstable” and those with no history of CVA were classified as stable. All patients underwent comprehensive baseline laboratory testing at baseline prior to CEA and then were followed by a nurse coordinator and through the medical record for the development of cerebrovascular events including stroke and transient ischemic attack for a median of 10.9 years (IQR 7.3, 13.4). Results: Baseline uric acid was significantly higher in patients presenting with unstable plaque vs. stable plaque(6.5 (IQR 5.6, 7.9) vs. 5.8(IQR 4.8,6.6); p<0.001), and was an independent predictor of plaque stability when adjusting for potential confounders including glucose, BMI, hsCRP, cholesterol, and systolic blood pressure (L-R 6.9, p=0.0096). There were a total of 58 CVA during follow-up, and baseline uric acid was higher among patients who developed CVA vs those without CVA [(6.9 + 2.1) mg/dL vs. (6.4 + 1.7) mg/dL; p=0.037]. After adjusting for diabetes, cholesterol, systolic blood pressure, smoking , age, aspirin, and creatinine, uric acid and cholesterol were both independent predictors of stroke in this population [uric acid: (LR 4.84, p=0.03); cholesterol: (L-R 11.8, p=0.0006)]. Discussion: While cholesterol has been associated with poor outcomes in patients with vascular disease, our data suggest that uric acid may be a novel risk factor for stroke in patients undergoing CEA. Further investigation is necessary to understand the therapeutic potential of reducing uric acid levels in these patients and the potential benefit of reducing overall cerebrovascular risk.
Abstract 155: High sensitivity C-Reactive Protein Predicts Future Cerebrovascular Events in Patients Undergoing Carotid Endarterectomy
Prasad, Megha , Nardi, Valentina , Lerman, Lilach O. , Lerman, Amir , Nardi, Valentina

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 12, 2019 | Volume: 38 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.38.suppl_1.155 Get It

Background: High sensitivity C-reactive protein is a risk factor atherosclerosis and plaque rupture. We aimed to determine the role of high-sensitivity C reactive protein in predicting future cerebrovascular events (CVA), including stroke and transient ischemic attack, in patients undergoing routine carotid endarterectomy (CEA). Methods: A total of 251 patients underwent routine CEA without any history of stroke. At baseline prior to CEA, patients underwent routine laboratory testing, including testing for novel biomarkers including hs-CRP. Patients were followed for a median of 10.9 years (IQR 7.3, 13.4) for the development of CVA with regular nursing follow-up and/or chart review. Results: Of 251 patients enrolled in the study, 19 patients without prior CVA subsequently developed CVA during follow-up. In univariate analysis, baseline hsCRP was significantly higher in patients who developed CVA during follow-up vs. those that did not (8.1 (IQR 2.2, 46.3) mg/L vs. 3.85(0.9, 11.75) mg/L; p=0.0054)(Figure 1). After adjusting for confounders including age. diabetes mellitus, cholesterol, systolic blood pressure, history of smoking, aspirin use and duration of follow-up, log hsCRP was an independent predictor of CVA during follow-up after CEA (L-R 9.9; p=0.0016). Discussion: Hs-CRP appears to be a risk factor for CVA during follow-up after CEA. Further investigation is necessary to determine the role of risk modification in these patients and the therapeutic potential of reducing inflammation in this population.
A novel measure of glucose homeostasis (or loss thereof) comprising the joint dynamics of glucose, insulin, glucagon, and cortisol
Keenan, Daniel M., Veldhuis, Johannes D. , Basu, Ananda , Basu, Rita

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | March 12, 2019 | Volume: 316 | Issue: 6 | Pages: E998-E1011

10.1152/ajpendo.00078.2018 | PMID 30860881 Get It

Quantification of disturbances in glucose-insulin homeostasis has been the cornerstone of appraising insulin resistance and detecting early-stage diabetes. Metabolic homeostasis arises from feedback and feed-forward interactions among (at least) all four of glucose, insulin, glucagon, and cortisol. Quantifying such tetrapartite interactions in the fasting (endogenously regulated) state overnight could elucidate very early regulatory disruption. In the present study, healthy subjects without diabetes (ND; n = 20) and patients with Type 2 diabetes (T2D; n = 21) were investigated by repeated overnight blood sampling of all four of glucose, insulin, glucagon, and cortisol concentrations. To obviate confounding by hormone-specific disappearance rates, analyses were performed at the level of production (glucose) or secretion (insulin, glucagon, and cortisol) rates estimated by regularized deconvolution analysis. Then, a novel method for quantifying the loss of homeostasis among glucose, insulin, and glucagon (and, when available, cortisol) secretion patterns was developed. Potential early stage prediabetic candidates were identified. The new methodology avoids many of the difficulties encountered in the conventional estimation of insulin-glucose sensitivity or resistance, while incorporating the dynamics of the key coregulators under fasting conditions.
716. Pilot: Effectiveness & Safety of Non-Surgical Spinal Decompression
Richmond, Charlotte, Leslie, John B., Macario, Alex, Apfel, Christian C., Florio, F., Auster, Martin, Pergolizzi, Joseph V.

Mayo Clinic

Regional Anesthesia & Pain Medicine | March 12, 2019 | Volume: 33 | Issue: Suppl 1 | Pages: e219.1-e219

10.1136/rapm-00115550-200809001-00424 Get It

460. Cauda Equina Syndrome Following Spinal Anaesthesia With Procaine
Johnson, Mark C. , Swanson, Jerry W., Johnson, M.

Mayo Clinic

Regional Anesthesia & Pain Medicine | March 12, 2019 | Volume: 33 | Issue: Suppl 1 | Pages: e38.2-e38

10.1136/rapm-00115550-200809001-00067 Get It

Current Practice Trends in Image Guidance During Lumbar and Cervical Transforaminal Epidural Steroid Injections
Vydra, Darrell , Hynes, Alexander, Clements, Nate, Julia, Jonathon, Schneider, Byron J. , Maus, Timothy P. , Cushman, Daniel M. , McCormick, Zachary L. , Nagpal, Ameet

Mayo Clinic

Pain Medicine | March 12, 2019 | Volume: 20 | Issue: 11 | Pages: 2327-2329

10.1093/pm/pnz065 | PMID 30938803 Get It

Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models
Kaiser, Robert A. , Nicolas, Clara T., Allen, Kari L. , Chilton, Jennifer A., Du, Zeji , Lillegard, Joseph B. , Kaiser, Robert Allen, Nicolas, Clara Teresa, Allen, Kari Lynn, Hickey, Raymond Daniel, Lillegard, Joseph Benjamin, Hickey, Raymond

Mayo Clinic

Human Gene Therapy Clinical Development | March 12, 2019 | Volume: 30 | Issue: 2 | Pages: 57-66

10.1089/humc.2018.249 | PMID 30860398 Get It

Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”
Iwamoto, Sean J. , T’Sjoen, Guy , Safer, Joshua D. , Davidge‐Pitts, Caroline , Wierman, Margaret E. , Glodowski, Michele , Iwamoto, Sean J , Safer, Joshua D , Rothman, Micol Sara

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 12, 2019 | Volume: 104 | Issue: 8 | Pages: 3127-3128

10.1210/jc.2019-00249 | PMID 30860591 Get It

CT Characteristics and Pathologic Basis of Solitary Cystic Lung Cancer
Mergo, Patricia J. , Rojas, Carlos A.

Mayo Clinic

Radiology | March 12, 2019 | Volume: 291 | Issue: 2 | Pages: 502-503

10.1148/radiol.2019190329 | PMID 30860447 Get It